These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 19136271

  • 1. Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer.
    Taylor MD, Smith PW, Brix WK, Wick MR, Theodosakis N, Swenson BR, Kozower BD, Jones DR.
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):699-705. PubMed ID: 19136271
    [Abstract] [Full Text] [Related]

  • 2. Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
    Taylor MD, Smith PW, Brix WK, Wick MR, Theodosakis N, Swenson BR, Kozower BD, Lau CL, Jones DR.
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):43-8. PubMed ID: 19154901
    [Abstract] [Full Text] [Related]

  • 3. Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer.
    Duan XY, Wang W, Wang JS, Shang J, Gao JG, Guo YM.
    BMC Cancer; 2013 Nov 15; 13():546. PubMed ID: 24237755
    [Abstract] [Full Text] [Related]

  • 4. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A.
    Eur J Cardiothorac Surg; 2013 Aug 15; 44(2):e105-12. PubMed ID: 23674658
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
    Schreurs LM, Smit JK, Pavlov K, Pultrum BB, Pruim J, Groen H, Hollema H, Plukker JT.
    Ann Surg Oncol; 2014 Nov 15; 21(12):3751-7. PubMed ID: 24939624
    [Abstract] [Full Text] [Related]

  • 6. Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).
    Miyata H, Yamasaki M, Takahashi T, Murakami K, Tanaka K, Yukinori K, Nakajima K, Takiguchi S, Morii E, Hatazawa J, Mori M, Doki Y.
    Ann Surg Oncol; 2014 Feb 15; 21(2):575-82. PubMed ID: 24201746
    [Abstract] [Full Text] [Related]

  • 7. Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
    Hirose Y, Kaida H, Kawahara A, Matono S, Tanaka T, Kurata S, Kage M, Ishibashi M, Abe T.
    Nucl Med Commun; 2016 Oct 15; 37(10):1053-61. PubMed ID: 27218430
    [Abstract] [Full Text] [Related]

  • 8. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
    Kitasato Y, Yasunaga M, Okuda K, Kinoshita H, Tanaka H, Okabe Y, Kawahara A, Kage M, Kaida H, Ishibashi M.
    Pancreas; 2014 Oct 15; 43(7):1060-5. PubMed ID: 25121413
    [Abstract] [Full Text] [Related]

  • 9. Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation.
    Arnett ALH, Merrell KW, Macintosh EM, James SE, Nathan MA, Shen KR, Ravi K, Neben Wittich MA, Haddock MG, Hallemeier CL.
    J Thorac Oncol; 2017 Jan 15; 12(1):121-128. PubMed ID: 27569732
    [Abstract] [Full Text] [Related]

  • 10. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer.
    Vallböhmer D, Hölscher AH, Dietlein M, Bollschweiler E, Baldus SE, Mönig SP, Metzger R, Schicha H, Schmidt M.
    Ann Surg; 2009 Dec 15; 250(6):888-94. PubMed ID: 19953708
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, Lee JY, Lee KH, Kim BT.
    Ann Surg Oncol; 2010 Jan 15; 17(1):115-22. PubMed ID: 19826877
    [Abstract] [Full Text] [Related]

  • 12. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Cancer; 2004 Oct 15; 101(8):1776-85. PubMed ID: 15386332
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Yap WK, Chang YC, Tseng CK, Hsieh CH, Chao YK, Su PJ, Hou MM, Yang CK, Pai PC, Lin CR, Hsieh CE, Wu YY, Hung TM.
    Dis Esophagus; 2017 Aug 01; 30(8):1-10. PubMed ID: 28575243
    [Abstract] [Full Text] [Related]

  • 14. PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.
    Lindner K, Palmes D, Senninger N, Hummel R.
    Langenbecks Arch Surg; 2015 Feb 01; 400(2):229-35. PubMed ID: 25572665
    [Abstract] [Full Text] [Related]

  • 15. Correlation between maximum standardized uptake values on FDG-PET and microenvironmental factors in patients with clinical stage IA radiologic pure-solid lung adenocarcinoma.
    Ichikawa T, Aokage K, Miyoshi T, Tane K, Suzuki K, Makinoshima H, Tsuboi M, Ishii G.
    Lung Cancer; 2019 Oct 01; 136():57-64. PubMed ID: 31445355
    [Abstract] [Full Text] [Related]

  • 16. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL.
    J Thorac Oncol; 2014 Aug 01; 9(8):1202-6. PubMed ID: 25157774
    [Abstract] [Full Text] [Related]

  • 17. The relationship between GLUT-1 and vascular endothelial growth factor expression and 18F-FDG uptake in esophageal squamous cell cancer patients.
    Kobayashi M, Kaida H, Kawahara A, Hattori S, Kurata S, Hayakawa M, Hirose Y, Uchida M, Kage M, Fujita H, Hayabuchi N, Ishibashi M.
    Clin Nucl Med; 2012 May 01; 37(5):447-52. PubMed ID: 22475893
    [Abstract] [Full Text] [Related]

  • 18. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
    Piessen G, Petyt G, Duhamel A, Mirabel X, Huglo D, Mariette C.
    Ann Surg; 2013 Jul 01; 258(1):66-76. PubMed ID: 23470576
    [Abstract] [Full Text] [Related]

  • 19. Is 18F-FDG-PET useful for predicting R0 resection after induction therapy for initially unresectable locally advanced esophageal carcinoma?
    Sugimura K, Miyata H, Yano M, Yanagimoto Y, Ho MJ, Kobayashi S, Takahashi H, Omori T, Ohue M, Sakon M.
    Gen Thorac Cardiovasc Surg; 2017 Aug 01; 65(8):455-462. PubMed ID: 28585161
    [Abstract] [Full Text] [Related]

  • 20. 18F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer.
    Mantziari S, Pomoni A, Prior JO, Winiker M, Allemann P, Demartines N, Schäfer M.
    BMC Med Imaging; 2020 Jan 22; 20(1):7. PubMed ID: 31969127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.